Calgary, Alberta and Amsterdam, Netherlands--(Newsfile Corp. - October 27, 2025) - Zenith Epigenetics Ltd. ("Zenith" or the "Company") is pleased to announce that the U.S. Food and Drug Administration ...
Calgary, Alberta--(Newsfile Corp. - April 9, 2026) - Zenith Epigenetic Ltd. ("Zenith" or the "Company") today held its annual general meeting of shareholders ("AGM"), during which President & CEO ...
In February 2022, Zenith Epigenetics Ltd. reported the dosing of the first patient with a combination of ZEN-3694 (BET inhibitor) + Bristol Myers Squibb’s PD-1 immune checkpoint inhibitor OPDIVO and ...
Article ‘Count’ and ‘Share’ for Zenith Epigenetics Corp. based on listed parameters only. The articles listed below published by authors from Zenith Epigenetics Corp., organized by journal and article ...
April 09, 2026 4:00 PM EDT | Source: Zenith Capital Corp. Calgary, Alberta--(Newsfile Corp. - April 9, 2026) - Zenith Epigenetic Ltd. ("Zenith" or the "Company") today held its annual general meeting ...
Calgary, Alberta--(Newsfile Corp. - April 9, 2026) - Zenith Epigenetic Ltd. ("Zenith" or the "Company") today held its annual general meeting of shareholders ("AGM"), during which President & CEO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results